Breadcrumb

Breadcrumbs

PAGE UNDER CONSTRUCTION

PAGE UNDER CONSTRUCTION

Antibody Drug Conjugate (ADC) Franchise

AML Franchise more stories content

More Stories

AML Franchise

The investigational Acute Myeloid Leukemia (AML) Franchise of the Daiichi Sankyo Cancer Enterprise is pushing the boundaries of science aiming to define a new standard of care for patients with AML, a fast-growing form of leukemia that has the lowest 5-year survival rate of all leukemias.

read more ...